Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention
NCT ID: NCT03613493
Last Updated: 2019-08-02
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
175 participants
INTERVENTIONAL
2018-07-10
2018-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using CHWs and HPV Home Tests to Increase Cervical Cancer Screening in Minority Populations
NCT02121548
HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women
NCT03012932
HPV Self-sampling for Underscreened Latinas
NCT06439706
The Effectiveness, Cost-effectiveness, and Budget Impact of Interventions to Improve the Delivery of Cervical Cancer Screening in Puerto Rico.
NCT06943547
HPV Self-test to Increase Cervical Cancer Screening in Asian Women
NCT04612660
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HPV self-sampling kit + Interview
Participants will receive an HPV self-sampling kit to screen for HPV and then are interviewed about their experience using the tool.
HPV self-sampling kit
The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.
Interview
Participants will be interviewed about experiences using the self-sampling tool (qualitative).
Culturally-targeted Fear appeal message HPV self-sampling kit
Participants will receive an HPV self-sampling kit to screen for HPV, accompanied by a culturally-targeted fear appeal message
HPV self-sampling kit
The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.
Culturally-targeted Fear Appeal Message
Participants will receive culturally-targeted and fear appeal messages in a graphically designed kit.
Fear appeal message HPV self-sampling kit
Participants will receive an HPV self-sampling kit to screen for HPV, accompanied by a culturally-targeted fear appeal message
HPV self-sampling kit
The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.
Fear Appeal Message
Participants will receive fear appeal messages (only) in a graphically designed kit.
HPV self-sampling kit
Participants will receive an HPV self-sampling kit to screen for HPV
HPV self-sampling kit
The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HPV self-sampling kit
The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling.
Culturally-targeted Fear Appeal Message
Participants will receive culturally-targeted and fear appeal messages in a graphically designed kit.
Fear Appeal Message
Participants will receive fear appeal messages (only) in a graphically designed kit.
Interview
Participants will be interviewed about experiences using the self-sampling tool (qualitative).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* have had a history of cervical cancer,
* Women who are currently up-to-date on cervical cancer screening (have had a Pap in the last 3 years or have had a Pap smear/HPV co-test within the past 5 years),
* Adults unable to consent, children, pregnant women and prisoners.
30 Years
65 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Miami
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Susan Morgan
Associate Provost for Research Development and Strategy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susan E Morgan, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Miami
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20180033
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.